SCHEMBL4199961

SCHEMBL4199961

COc1cccc(S(=O)(=O)Cc2ccc(Cl)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MAPT P10636 2/20 0.51
GAA P10253 1/20 0.51
KDM1A O60341 1/20 0.48
MAOA P21397 1/20 0.48
NFE2L2 Q16236 2/20 0.48
TAS2R14 Q9NYV8 1/20 0.48
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
KDR P35968 1/20 0.47
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HTT P42858 2/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
LMNA P02545 1/20 0.45
PGR P06401 1/20 0.44
HSD11B1 P28845 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30963317 0.85 TAS2R14 (0.48) SMN1; SMN2NFE2L2TAS2R14ALDH1A1SIRT2
SCHEMBL4818070 0.85 PKM (0.50) SMN1; SMN2MAPTGAANFE2L2ALDH1A1
SCHEMBL4818974 0.81 EGFR (0.56) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL14303718 0.78 DYRK1A (0.50) MAPTGAANFE2L2ALDH1A1SIRT2
SCHEMBL6208314 0.77 HSD11B1 (0.53) MEN1KMT2AMAPTGAANFE2L2
SCHEMBL4250924 0.77 HSD11B1 (0.53) GAANFE2L2TAS2R14PGRHSD11B1
SCHEMBL4209577 0.77 ALDH1A1 (0.59) SMN1; SMN2MAPTTAS2R14ALDH1A1PGR
SCHEMBL3427100 0.77 NFE2L2 (0.48) MEN1KMT2ASMN1; SMN2MAPTGAA
SCHEMBL9820015 0.76 MAPT (0.61) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL4188124 0.75 HSD11B1 (0.48) SMN1; SMN2NFE2L2TAS2R14PGRHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090012308-A1 PROCESS FOR THE MANUFACTURE OF BENZYLSULFONYLARENES WYETH (US) 2009-01-08 US disclosed
WO-2008157216-A1 PROCESS FOR THE MANUFACTURE OF BENZYLSULFONYLARENES WYETH (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012308-A1 PROCESS FOR THE MANUFACTURE OF BENZYLSULFONYLARENES HTR6, HTR2B, HTR3B MEN1 2376/4885KMT2A 648/4885SMN1; SMN2 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.